| scholarly article | Q13442814 |
| P819 | ADS bibcode | 1996PNAS...93.9699L |
| P356 | DOI | 10.1073/PNAS.93.18.9699 |
| P932 | PMC publication ID | 38492 |
| P698 | PubMed publication ID | 8790394 |
| P5875 | ResearchGate publication ID | 14413418 |
| P2093 | author name string | S Y Lee | |
| Y Choi | |||
| H C Liou | |||
| G Kandala | |||
| M L Liou | |||
| P2860 | cites work | A novel RING finger protein interacts with the cytoplasmic domain of CD40 | Q24306382 |
| Involvement of CRAF1, a relative of TRAF, in CD40 signaling | Q24306746 | ||
| CD30 antigen, a marker for Hodgkin's lymphoma, is a receptor whose ligand defines an emerging family of cytokines with homology to TNF | Q24316162 | ||
| TRADD-TRAF2 and TRADD-FADD interactions define two distinct TNF receptor 1 signal transduction pathways | Q24317441 | ||
| A novel family of putative signal transducers associated with the cytoplasmic domain of the 75 kDa tumor necrosis factor receptor | Q24318280 | ||
| Cdi1, a human G1 and S phase protein phosphatase that associates with Cdk2 | Q24319816 | ||
| Molecular cloning and expression of a new member of the nerve growth factor receptor family that is characteristic for Hodgkin's disease | Q24324634 | ||
| T cell receptor-dependent cell death of T cell hybridomas mediated by the CD30 cytoplasmic domain in association with tumor necrosis factor receptor-associated factors | Q24678367 | ||
| A B-lymphocyte activation molecule related to the nerve growth factor receptor and induced by cytokines in carcinomas | Q28115527 | ||
| The TNFR2-TRAF signaling complex contains two novel proteins related to baculoviral inhibitor of apoptosis proteins | Q28117866 | ||
| The Epstein-Barr virus transforming protein LMP1 engages signaling proteins for the tumor necrosis factor receptor family | Q28307399 | ||
| TRAF2-mediated activation of NF-kappa B by TNF receptor 2 and CD40 | Q28610812 | ||
| The TNF receptor superfamily of cellular and viral proteins: activation, costimulation, and death | Q29620519 | ||
| Cloning and expression of cDNAs for two distinct murine tumor necrosis factor receptors demonstrate one receptor is species specific | Q33336314 | ||
| A receptor for tumor necrosis factor defines an unusual family of cellular and viral proteins | Q33909940 | ||
| CD30, Th2 cytokines and HIV infection: a complex and fascinating link | Q40611296 | ||
| Tumor necrosis factor receptor superfamily members and their ligands | Q40626257 | ||
| Cross-linking of CD30 induces HIV expression in chronically infected T cells | Q41342620 | ||
| Sequential induction of NF-kappa B/Rel family proteins during B-cell terminal differentiation | Q41450875 | ||
| Pleiotropic effects of the CD30 ligand on CD30-expressing cells and lymphoma cell lines. | Q41474009 | ||
| Differential increase of an alternatively polyadenylated mRNA species of murine CD40 upon B lymphocyte activation | Q42602122 | ||
| Structure and expression of murine CD30 and its role in cytokine production | Q42817475 | ||
| Residues of the variable region of the T-cell-receptor β-chain that interact with S. aureus toxin superantigens | Q56922307 | ||
| CD30 is a signal-transducing molecule that defines a subset of human activated CD45RO+ T cells | Q72230108 | ||
| Unraveling function in the TNF ligand and receptor families | Q72393346 | ||
| P433 | issue | 18 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | NF-κB | Q411114 |
| TNF | Q18032037 | ||
| P304 | page(s) | 9699-9703 | |
| P577 | publication date | 1996-09-01 | |
| P1433 | published in | Proceedings of the National Academy of Sciences of the United States of America | Q1146531 |
| P1476 | title | CD30/TNF receptor-associated factor interaction: NF-kappa B activation and binding specificity | |
| P478 | volume | 93 |
| Q102054075 | A novel model of alternative NF-κB pathway activation in anaplastic large cell lymphoma |
| Q42165830 | A regulatory role for TRAF1 in antigen-induced apoptosis of T cells. |
| Q39392332 | AP-1 mediated relief of repressive activity of the CD30 promoter microsatellite in Hodgkin and Reed-Sternberg cells |
| Q24321707 | ATAR, a novel tumor necrosis factor receptor family member, signals through TRAF2 and TRAF5 |
| Q38737500 | ATVB Distinguished Scientist Award: How Costimulatory and Coinhibitory Pathways Shape Atherosclerosis |
| Q40813696 | Activation of c-Jun N-terminal kinase in the absence of NFkappaB function prior to induction of NK cell death triggered by a combination of anti-class I and anti-CD16 antibodies |
| Q40954925 | Alymphoplasia is caused by a point mutation in the mouse gene encoding Nf-kappa b-inducing kinase |
| Q33699315 | Antigen presenting cells integrate opposing signals from CD4+ and CD8+ regulatory T lymphocytes to arbitrate the outcomes of immune responses |
| Q34582700 | Antigen-independent signalosome of CARMA1, PKCθ, and TNF receptor-associated factor 2 (TRAF2) determines NF-κB signaling in T cells |
| Q41921207 | CD30 Is Dispensable for T-Cell Responses to Influenza Virus and Lymphocytic Choriomeningitis Virus Clone 13 but Contributes to Age-Associated T-Cell Expansion in Mice |
| Q42199195 | CD30 expression in de novo diffuse large B-cell lymphoma: a population-based study from British Columbia |
| Q42176281 | CD30 is required for activation of a unique subset of interleukin-17A-producing γδ T cells in innate immunity against Mycobacterium bovis Bacillus Calmette-Guerin infection |
| Q33747241 | CD30 ligand (CD30L)-expressing acute myeloid leukemias: a new model of paracrine interactions for the regulation of blast cells proliferation. |
| Q40810972 | CD30-mediated cell cycle arrest associated with induced expression of p21(CIP1/WAF1) in the anaplastic large cell lymphoma cell line Karpas 299. |
| Q46261367 | CD30L/CD30 is critical for maintenance of IL-17A-producing γδ T cells bearing Vγ6 in mucosa-associated tissues in mice |
| Q40636873 | CD40 signaling through a newly identified tumor necrosis factor receptor-associated factor 2 (TRAF2) binding site |
| Q61442999 | CDC37 as a novel target for the treatment of NPM1-ALK expressing anaplastic large cell lymphomas |
| Q42631651 | Characterization and expression analysis of TNFR-associated factor 1 (TRAF1) in grass carp Ctenopharyngodon idella |
| Q39879963 | Characterization of LMP-1's association with TRAF1, TRAF2, and TRAF3. |
| Q40733134 | Cytoplasmic aggregation of TRAF2 and TRAF5 proteins in the Hodgkin-Reed-Sternberg cells |
| Q42441496 | Differential expression and function of A20 and TRAF1 in Hodgkin lymphoma and anaplastic large cell lymphoma and their induction by CD30 stimulation |
| Q34428468 | Distinct motifs in the intracellular domain of human CD30 differentially activate canonical and alternative transcription factor NF-κB signaling |
| Q28255713 | Dominant negative mutants of TRAF3 reveal an important role for the coiled coil domains in cell death signaling by the lymphotoxin-beta receptor |
| Q29618716 | Early lethality, functional NF-kappaB activation, and increased sensitivity to TNF-induced cell death in TRAF2-deficient mice |
| Q39988374 | Enhanced susceptibility to Con A-induced liver injury in mice transgenic for the intracellular isoform of human TNF receptor type 2. |
| Q36942675 | Evaluation of serum levels of sCD30L ligand in patients with ovarian cancer in terms of selected clinico-pathological factors |
| Q79439040 | Evaluation of soluble CD30 as an immunologic marker in heart transplant recipients |
| Q38462802 | Expression of the tumor necrosis factor receptor-associated factors (TRAFs) 1 and 2 is a characteristic feature of Hodgkin and Reed-Sternberg cells |
| Q37314736 | Frequent engagement of the classical and alternative NF-kappaB pathways by diverse genetic abnormalities in multiple myeloma |
| Q35788035 | Frequent expression of the variant CD30 in human malignant myeloid and lymphoid neoplasms |
| Q33713375 | Gene targeting in the analysis of mammalian apoptosis and TNF receptor superfamily signaling |
| Q27473152 | Hepatitis C virus nonstructural 5B protein regulates tumor necrosis factor alpha signaling through effects on cellular IkappaB kinase |
| Q24323286 | Herpesvirus entry mediator, a member of the tumor necrosis factor receptor (TNFR) family, interacts with members of the TNFR-associated factor family and activates the transcription factors NF-kappaB and AP-1 |
| Q28207526 | Hodgkin's lymphoma and CD30 signal transduction |
| Q28245341 | Identification and characterization of an IkappaB kinase |
| Q73980580 | Identification and characterization of two CD40-inducible enhancers in the mouse TRAF1 gene locus |
| Q39215639 | Immune checkpoint proteins: exploring their therapeutic potential to regulate atherosclerosis |
| Q51003096 | Innate memory phenotype CD4+ T cells play a role in early protection against infection by Listeria monocytogenes in a CD30L-dependent manner. |
| Q42087613 | Involvement of Sp1 and microsatellite repressor sequences in the transcriptional control of the human CD30 gene |
| Q40736248 | Ligand-independent signaling by overexpressed CD30 drives NF-kappaB activation in Hodgkin-Reed-Sternberg cells |
| Q36959865 | Lymphoma microenvironment: culprit or innocent? |
| Q24522758 | Molecular determinants of NF-kappaB-inducing kinase action |
| Q40558909 | Molecular study on chicken tumor necrosis factor receptor-II and tumor necrosis factor receptor-associated factor-5. |
| Q42807549 | Murine Siva-1 and Siva-2, alternate splice forms of the mouse Siva gene, both bind to CD27 but differentially transduce apoptosis |
| Q33958468 | Mutant cells that do not respond to interleukin-1 (IL-1) reveal a novel role for IL-1 receptor-associated kinase |
| Q28611795 | MyD88: an adapter that recruits IRAK to the IL-1 receptor complex |
| Q36771224 | Need for an improved molecular/genetic classification for CD30+ lymphomas involving the skin |
| Q24292240 | Nonstructural 5A protein of hepatitis C virus modulates tumor necrosis factor alpha-stimulated nuclear factor kappa B activation |
| Q35175282 | Nuclear transcription factor-kappaB in Hodgkin's disease |
| Q28208696 | Pleiotropic signal transduction mediated by human CD30: a member of the tumor necrosis factor receptor (TNFR) family |
| Q51969986 | Pre-transplant level of soluble CD30 is associated with infection after heart transplantation. |
| Q38842875 | Protein Kinase C Isoforms Differentially Regulate Hypoxia-Inducible Factor-1α Accumulation in Cancer Cells |
| Q73783872 | Rapid communication. Enalapril decreases nuclear factor kappa B activation in the kidney with ureteral obstruction |
| Q28243232 | Ras promotes transforming growth factor-β (TGF-β)-induced epithelial-mesenchymal transition via a leukotriene B4 receptor-2-linked cascade in mammary epithelial cells |
| Q78631997 | Regulation of lymphocyte clustering by CD30-mediated ICAM-1 up-regulation |
| Q36371153 | Regulation of the subcellular localization of tumor necrosis factor receptor-associated factor (TRAF)2 by TRAF1 reveals mechanisms of TRAF2 signaling |
| Q32054925 | Selection of phage displayed peptides from a random 10-mer library recognising a peptide target. |
| Q34187808 | Senescence, apoptosis and therapy--cutting the lifelines of cancer. |
| Q22009150 | Signalling through CD30 protects against autoimmune diabetes mediated by CD8 T cells |
| Q35021163 | T cell-NF-κB activation is required for tumor control in vivo |
| Q30578474 | TNF receptor associated factors in cytokine signaling. |
| Q37266849 | TNF superfamily: costimulation and clinical applications |
| Q40644972 | TNF-related weak inducer of apoptosis receptor, a TNF receptor superfamily member, activates NF-kappa B through TNF receptor-associated factors |
| Q24678181 | TRAF-4 expression in epithelial progenitor cells. Analysis in normal adult, fetal, and tumor tissues |
| Q24313308 | TRAF-interacting protein (TRIP): a novel component of the tumor necrosis factor receptor (TNFR)- and CD30-TRAF signaling complexes that inhibits TRAF2-mediated NF-kappaB activation |
| Q73925277 | TRAF2 is essential for JNK but not NF-kappaB activation and regulates lymphocyte proliferation and survival |
| Q28587065 | TRAF4 deficiency leads to tracheal malformation with resulting alterations in air flow to the lungs |
| Q35997566 | The Epstein-Barr virus LMP1 amino acid sequence that engages tumor necrosis factor receptor associated factors is critical for primary B lymphocyte growth transformation |
| Q24554457 | The Epstein-Barr virus oncoprotein latent membrane protein 1 engages the tumor necrosis factor receptor-associated proteins TRADD and receptor-interacting protein (RIP) but does not induce apoptosis or require RIP for NF-kappaB activation |
| Q36940326 | The TNF Receptor Superfamily in Co-stimulating and Co-inhibitory Responses |
| Q28589608 | The TNF receptor family member CD27 signals to Jun N-terminal kinase via Traf-2 |
| Q39897508 | The aryl hydrocarbon nuclear translocator alters CD30-mediated NF-kappaB-dependent transcription |
| Q53234746 | The central role of CD30L/CD30 interactions in allergic rhinitis pathogenesis in mice. |
| Q39070848 | The role of CD30 and CD153 (CD30L) in the anti-mycobacterial immune response |
| Q40905330 | The tyrosine kinase NPM-ALK, associated with anaplastic large cell lymphoma, binds the intracellular domain of the surface receptor CD30 but is not activated by CD30 stimulation |
| Q28140478 | The ubiquitin-homology protein, DAP-1, associates with tumor necrosis factor receptor (p60) death domain and induces apoptosis |
| Q24682087 | The zinc finger protein A20 inhibits TNF-induced NF-kappaB-dependent gene expression by interfering with an RIP- or TRAF2-mediated transactivation signal and directly binds to a novel NF-kappaB-inhibiting protein ABIN |
| Q40375572 | Transactivation of the ICAM-1 gene by CD30 in Hodgkin's lymphoma |
| Q41056335 | Tumor necrosis factor receptor (TNFR)-associated factor 2A (TRAF2A), a TRAF2 splice variant with an extended RING finger domain that inhibits TNFR2-mediated NF-kappaB activation |
| Q34135071 | Tumor necrosis factor receptor-associated factor (TRAF) 2 and its role in TNF signaling. |
| Q36400170 | Tumor necrosis factor receptor-associated factor 6 (TRAF6) stimulates extracellular signal-regulated kinase (ERK) activity in CD40 signaling along a ras-independent pathway. |
| Q28199382 | Tumor necrosis factor receptor-associated factors (TRAFs) |
| Q24676338 | Two differently regulated nuclear factor kappaB activation pathways triggered by the cytoplasmic tail of CD40 |
| Q37179796 | Two distinct signalling cascades target the NF-kappaB regulatory factor c-IAP1 for degradation |
Search more.